Protein S deficiency is a condition in which this natural blood-clotting regulator is too low or does not work properly, raising the risk of unwanted blood clots. Protein S normally acts as a helper protein that keeps your coagulation system in balance, so a shortage can tip that balance toward excessive clotting. This article explains what protein S does, how to read the total, free, and activity values on your lab report, what causes a low result, and why timing matters so much for accurate interpretation. It also covers recent research on how clinicians decide when testing is actually useful.
What is protein S and what does it do?
Protein S is a protein made mainly by the liver that circulates in your blood plasma. Endothelial cells, which line the inside of your blood vessels, also produce a smaller amount. Roughly 60% of protein S in the bloodstream binds to another protein called C4b-binding protein and becomes inactive, while the remaining 40% circulates freely. This free fraction is the biologically active portion that does the work.
Protein S functions as a cofactor, meaning it boosts the effectiveness of another molecule rather than acting alone. Its partner is activated protein C, a natural anticoagulant that breaks down two clotting factors, factor Va and factor VIIIa, once a clot has done its job. Protein S speeds up this breakdown considerably. Without enough functional protein S, activated protein C works far less efficiently, and clotting factors can remain active longer than they should. Doctors investigating an unexplained clot often check this related natural anticoagulant protein at the same time, since a shortage of either can point to a shared underlying problem.
Why this regulation matters
Blood clotting is a carefully balanced system. Clotting factors need to activate quickly enough to stop bleeding after an injury, but natural anticoagulants like protein S, protein C, and antithrombin need to switch that activity off once the repair is complete. When one of these brakes is missing or weak, the system can tip toward forming clots inside blood vessels where none are needed, a state called thrombophilia. A related natural anticoagulant plays a similar regulatory role, and readers can explore antithrombin III testing and its clinical significance for a fuller picture of the system.
Why doctors order a protein S test
A protein S test is not part of routine bloodwork. Doctors typically order it when investigating a coagulation disorder, most often after a person has had venous thrombosis, meaning an abnormal blood clot in a vein, without an obvious cause. This includes deep vein thrombosis, in which a clot forms in a deep vein of the leg, and pulmonary embolism, a clot that travels to the lungs and blocks blood flow. Readers wanting the full clinical picture can consult a detailed guide to pulmonary embolism symptoms and diagnosis. The test is also considered when a first clot happens at a young age, when clots recur, or when there is a strong family history of clotting problems.
Because testing for inherited clotting disorders carries real costs and can produce misleading results if done at the wrong time, current hematology guidance is more selective than it once was about who should be tested. A 2023 American Society of Hematology guideline notes that thrombophilia testing, including protein S, is best reserved for specific situations, such as a family history of protein S, protein C, or antithrombin deficiency when the result would change a decision about starting hormonal contraception or preventive treatment (Middeldorp et al., Blood Advances, 2023). In other words, the test is most useful when the answer will actually change what happens next, not simply out of general curiosity after any clot. When a doctor does order testing, it is often part of a broader panel, and understanding how the full coagulation panel fits together helps explain why protein S rarely tells the whole story on its own.
Reading your protein S test results
When your report comes back, it may list one or more of three related measurements: total protein S, free protein S, and protein S activity. Each captures a different piece of information, and understanding the distinction helps you make sense of an abnormal flag. Readers who want a broader orientation first can review a general guide to reading blood test results before tackling this more specialized marker.
Total, free, and activity: what each column means
Total protein S antigen measures every molecule of the protein present, whether bound or free. Free protein S antigen measures only the unbound, active fraction, which is the piece that actually assists activated protein C. Protein S activity is a functional assay that tests how well the protein performs its job in a laboratory clotting reaction, rather than simply counting molecules. Because free protein S is the portion that does the biological work, most laboratories consider it the most clinically informative of the three when screening for a deficiency.
The table below shows a typical example of how these values might appear on a lab report, alongside common adult reference ranges. Your own laboratory’s printed range is always the one that applies to your result, since methods and populations differ between labs.
| 測定項目 | 反映する内容 | 成人の一般的な基準範囲 |
|---|---|---|
| Protein S, total antigen | All protein S molecules, bound and free | About 70–140% |
| Protein S, free antigen | Only the unbound, biologically active fraction | About 70–140% |
| Protein S activity | Functional performance in a clotting assay | About 65–140% |
Laboratories often use color coding or symbols such as an asterisk or an arrow to flag a result outside the printed range. A value in red, or one marked with a downward arrow, typically signals a level below normal. A single low value on one measurement, without the others, is less concerning than a pattern where free protein S and activity are both low, which more strongly suggests a genuine deficiency.
A short checklist for reading your report
A few simple steps can help you make sense of your results before your appointment. First, identify which type of measurement was performed, since total, free, and activity values are not interchangeable. Second, compare your result against the specific reference range printed on your report rather than a number found elsewhere. Third, check whether more than one measurement is abnormal, since agreement between free antigen and activity strengthens the finding. Fourth, note any situation that could temporarily lower your level, such as pregnancy or a recent illness. Finally, always let a healthcare professional interpret the complete picture, including your symptoms and history.
Why timing changes the result: pregnancy, hormones, and illness
Protein S levels are not fixed. Several common, non-disease situations can physiologically lower protein S, which is one of the most important practical nuances of this test. Getting the timing wrong is a leading reason a truly normal person can appear deficient, or vice versa.
Pregnancy naturally reduces protein S levels, often substantially, and this effect can persist for weeks after delivery. Expectant readers can review what blood tests during pregnancy typically involve to understand this pattern in a broader context. Estrogen-containing medications, including combined oral contraceptives and some forms of hormone replacement therapy, also lower protein S levels through a similar hormonal pathway. An acute blood clot itself can temporarily consume protein S as part of the clotting response, so testing during or shortly after an active thrombosis can produce a falsely low result that does not reflect a person’s true baseline. Anticoagulant therapy adds another layer of complexity: vitamin K antagonists such as warfarin reduce protein S production because the liver needs vitamin K to make the active form of the protein. This relationship connects directly to how vitamin K influences clotting test results, while some other assay types can be affected by different anticoagulant classes in ways that are specific to the laboratory method used.
Because of these overlapping influences, specialists increasingly emphasize that a single abnormal protein S result obtained during pregnancy, while on hormonal medication, during an acute clot, or while on certain anticoagulants should not be treated as a final diagnosis. The most reliable approach is testing well away from these situations, and confirming any abnormal finding with a repeat test once the temporary influence has passed. Anyone with surgery planned in the meantime can review what blood work before surgery generally includes to know what to expect.
Hereditary versus acquired protein S deficiency
Doctors classify low protein S into two broad categories, and the distinction matters for how it is managed long term.
遺伝性欠乏症
Hereditary protein S deficiency is a genetic condition caused by variants in the PROS1 gene, the gene that provides instructions for making protein S. It is typically inherited in an autosomal dominant pattern, meaning that inheriting just one altered copy from a parent is enough to increase clotting risk, and a person with the condition has roughly a 50% chance of passing the altered gene to each child. According to the National Library of Medicine, protein S deficiency is estimated to affect approximately 1 in 500 people, and venous thromboembolism occurs in about 50% to 60% of people who carry this deficiency over their lifetime. A rare, more severe form occurs when a variant is inherited from both parents, which can cause a serious clotting disorder in newborns called purpura fulminans.
後天性欠乏症
Acquired protein S deficiency develops later in life due to another medical situation rather than a gene change, and it is generally more common than the hereditary form. Recognized causes include pregnancy and the postpartum period, estrogen-containing medications, vitamin K antagonist anticoagulant therapy, significant liver disease since the liver is the main production site, nephrotic syndrome, which causes protein loss through the kidneys, certain autoimmune conditions such as lupus, and some acute infections. Because the underlying trigger is often temporary, acquired deficiency frequently resolves once the cause is treated or removed, unlike the lifelong hereditary form.
What an abnormal result can mean for your health
A confirmed protein S deficiency raises the risk of venous thromboembolism, the umbrella term covering both deep vein thrombosis and pulmonary embolism. People with hereditary protein S deficiency have a meaningfully elevated risk of a first clot compared with the general population, and clots often occur before age 45. Because many people with a mild deficiency never develop a clot in their lifetime, the finding is best understood as one risk factor among several, not a guarantee of future illness. Doctors often check a related fragment measured after a clot has started to break down, and readers can learn about how the D-dimer test complements a thrombophilia workup.
High protein S levels are much rarer and less well studied than deficiency. They have occasionally been reported in chronic inflammatory conditions or after stopping anticoagulant treatment, but the clinical significance of an elevated result remains unclear, and it is not generally treated as requiring intervention on its own.
最新の科学的進歩
Recent hematology literature has focused less on discovering protein S’s biology and more on refining exactly when and how testing should be used in practice, which directly affects how a result should be interpreted.
A 2023 evidence-based guideline from the American Society of Hematology reviewed the existing research on thrombophilia testing and concluded that testing the general population before starting combined oral contraceptives is not recommended, and that most other scenarios warrant only conditional, situation-specific testing, such as when a family history of protein S deficiency would influence a decision about hormone use or prevention around pregnancy (Middeldorp et al., Blood Advances, 2023). For readers, this means a protein S test is most valuable when a specific decision hinges on the answer, rather than as routine reassurance.
A detailed 2024 review in 血栓と止血に関するセミナー examined why protein S deficiency is considered the hardest of the classic hereditary thrombophilias to diagnose accurately. The review explains that protein S circulates in both bound and free forms, that no single laboratory assay reliably detects every type of deficiency, and that common interfering factors, including a genetic variant called factor V Leiden, can falsely lower protein S activity results without affecting antigen levels (Moore, 血栓と止血に関するセミナー, 2024). For readers, this underscores why doctors often repeat testing or use more than one assay type before confirming a true deficiency.
A 2025 case report published in Clinical Biochemistry illustrates this challenge directly. Clinicians described a young pregnant patient whose initial thrombophilia panel suggested protein S deficiency, but repeat testing eight months later, combined with genetic analysis of the PROS1 gene, showed that her results did not actually meet the criteria for a true deficiency once the effects of pregnancy and an interfering genetic variant were accounted for (Hansen et al., Clinical Biochemistry, 2025). For readers, this real case shows why a single abnormal result, especially during pregnancy, is not the end of the story and why retesting later matters.
A 2025 review for advanced practice nurses summarized current thinking across the five classic hereditary thrombophilias, including protein S deficiency, noting that most people who carry one of these traits never develop a clot, and that national guidelines increasingly discourage broad screening in favor of testing only when a positive result would change management or benefit family members (Tinkle, Journal of the American Association of Nurse Practitioners, 2026). For readers, this reinforces that a deficiency finding is a piece of a larger risk picture rather than a standalone verdict.
Finally, a 2025 editorial in Expert Review of Molecular Diagnostics discussed an ongoing debate in the field about whether genetic testing of the PROS1 gene should play a larger role alongside traditional functional and antigen assays when diagnosing protein S deficiency (Favaloro et al., Expert Review of Molecular Diagnostics, 2025). For readers, this signals that testing methods are still evolving, so it is worth asking your doctor which type of assay was used if your result is unclear.
受診のタイミング
Most people never need to think about protein S at all. Certain situations, however, call for prompt medical attention, and a prior protein S abnormality makes it especially important to recognize them quickly.
片方の脚や腕に突然の痛み、腫れ、赤み、または熱感が現れた場合は、深部静脈血栓症（DVT）の可能性があるため、すぐに医療機関を受診してください。突然の息切れ、呼吸時に悪化する胸の痛み、動悸、または血を吐く（喀血）などの症状は肺塞栓症を示す可能性があり、緊急の診察が必要です。突然の激しい頭痛や、顔のゆがみ・言葉が出にくいなど脳卒中のサインが見られる場合も、すぐに医療機関を受診してください。
Contact your doctor to discuss testing, without urgency, if you have had an unexplained blood clot before age 45, a venous clot in an unusual location such as the brain or abdomen, recurrent clots, or a strong family history of clotting disorders, particularly if a relative has a confirmed protein S, protein C, or antithrombin deficiency. Women considering estrogen-containing contraception or hormone therapy who have this family history should also raise it with their provider before starting treatment.
Following up on a confirmed deficiency
If protein S deficiency is confirmed after appropriate retesting, ongoing management is individualized rather than one-size-fits-all. Someone with a mild, asymptomatic deficiency and no personal history of clotting is generally managed very differently from someone who has already had a venous thromboembolism, who is more likely to need extended or lifelong anticoagulant therapy. Pregnancy, planned surgery, and prolonged immobility are situations where a known deficiency often prompts preventive measures, such as temporary blood-thinning medication, even in someone who has never had a clot before. Because these decisions depend heavily on individual history and the type of deficiency involved, they are made in partnership with a hematologist or the physician who ordered the original test. Patients preparing for these conversations can also browse a comprehensive glossary of key blood markers 関連する専門用語に慣れるために。
用語集
| 用語 | 定義 |
|---|---|
| Activated protein C | A natural anticoagulant that breaks down clotting factors Va and VIIIa; protein S is its cofactor. |
| Cofactor | A helper molecule that boosts the effectiveness of another protein without acting alone. |
| 深部静脈血栓症（DVT） | A blood clot that forms in a deep vein, most often in the leg. |
| Free protein S | 血液中のプロテインSのうち、タンパク質と結合していない部分で、生物学的に活性のある分画とされています。 |
| PROS1遺伝子 | プロテインSを作るための指示を提供する遺伝子で、変異があると遺伝性欠乏症を引き起こすことがあります。 |
| 肺塞栓症（PE） | A blood clot that travels to and blocks an artery in the lungs, a potentially life-threatening event. |
| 血栓性素因（血栓形成傾向） | A tendency of the blood to clot more easily than normal, whether inherited or acquired. |
| ビタミンK拮抗薬 | A class of anticoagulant, such as warfarin, that reduces the liver’s production of vitamin K-dependent clotting proteins, including protein S. |
| 静脈血栓塞栓症（VTE） | 静脈内に血栓が形成される状態の総称で、深部静脈血栓症（DVT）と肺塞栓症の両方を含みます。 |
よくある質問
Is protein S the same as protein C?
No, they are two distinct proteins that work together in the same regulatory system. Protein C is activated to become the enzyme that breaks down excess clotting factors, while protein S acts as its cofactor, meaning it makes that breakdown process work far more efficiently. A deficiency in either protein can independently raise the risk of thrombosis, and doctors often test both together when investigating unexplained clotting.
妊娠中にプロテインSが低い値で戻ってきたのはなぜですか？
妊娠中はプロテインSが一時的に低下する最も一般的な原因の一つです。妊娠に伴うホルモン変化によって血中濃度が自然に低下し、この影響は出産後も数週間続くことがあります。妊娠中に低い値が出ても、必ずしも真の欠乏症があるとは限りません。遺伝性の疾患が疑われる場合は、妊娠やホルモン変化が落ち着いた後に再検査を行うことが一般的に推奨されています。
How is a temporary deficiency told apart from a lifelong one?
A temporary, or acquired, deficiency generally returns to a normal range once the underlying cause resolves, such as after pregnancy ends, an anticoagulant is paused under medical supervision, or an acute illness clears. A hereditary deficiency, by contrast, remains persistently low across multiple tests performed at different times and in the absence of any temporary influence. Genetic testing of the PROS1 gene can sometimes help confirm a hereditary cause when the picture from standard blood tests alone is unclear.
Do newer blood thinners affect the protein S test?
Direct oral anticoagulants generally do not lower the actual concentration of protein S the way vitamin K antagonists do, but they can still interfere with some functional laboratory assays used to measure it, producing a misleading result. For this reason, testing is often best done before starting a direct oral anticoagulant, or after a temporary, medically supervised pause, so the result reflects your true baseline rather than a drug interaction with the assay.
Can a low protein S level cause bleeding instead of clotting?
No, protein S deficiency is specifically associated with an increased tendency toward clotting, not bleeding, because it removes one of the body’s natural brakes on coagulation. Bleeding can occur as a side effect of the anticoagulant medication sometimes prescribed to treat a confirmed deficiency, particularly if the dose is too high, but this comes from the treatment rather than from the deficiency itself.
Does a protein S deficiency affect pregnancy or fertility?
欠乏症は直接的に妊孕性を低下させるわけではありませんが、習慣性流産や子癇前症など、特定の妊娠合併症のリスクを高める可能性があります。これは、胎盤に影響を与える小さな血栓と関連していると考えられています。また、妊娠自体もホルモンの変化とは無関係な理由でプロテインSの値を低下させるため、欠乏症が判明している、または疑われる女性が妊娠中または妊娠を計画している場合は、産科チームによるより密な経過観察が一般的に行われます。
参考文献
- プロテインS欠乏症：概要・原因・症状・治療 — クリーブランドクリニック： https://my.clevelandclinic.org/health/diseases/21877-protein-s-deficiency
- プロテインS欠乏症 — MedlinePlus遺伝学、米国国立医学図書館（NIH）： https://medlineplus.gov/genetics/condition/protein-s-deficiency/
- 深部静脈血栓症（DVT）— 症状と原因、Mayo Clinic： https://www.mayoclinic.org/diseases-conditions/deep-vein-thrombosis/symptoms-causes/syc-20352557
- Middeldorp S, et al. American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing — Blood Advances, 2023 (PubMed)： https://doi.org/10.1182/bloodadvances.2023010177
- Moore GW. Thrombophilia Screening: Not So Straightforward — Seminars in Thrombosis and Hemostasis, 2024 (PubMed)： https://doi.org/10.1055/s-0044-1786807
- Hansen RS, et al. Diagnosing protein S deficiency – Navigating challenges — Clinical Biochemistry, 2025 (PubMed)： https://doi.org/10.1016/j.clinbiochem.2025.110950
- Tinkle MB. 遺伝性血栓性素因：遺伝学と検査に関する考慮事項 — Journal of the American Association of Nurse Practitioners, 2026 (PubMed)： https://doi.org/10.1097/JXX.0000000000001216
- Favaloro EJ, Moore GW, Pasalic L. Diagnosing thrombophilia: the case for genetic or functional testing? — Expert Review of Molecular Diagnostics, 2025 (PubMed)： https://doi.org/10.1080/14737159.2025.2588621
関連記事
- プロテインC：血液検査の結果をわかりやすく解説する完全ガイド
- 凝固検査の解説：PT、PTT、INR、Dダイマー
- アンチトロンビンIII検査：数値の見方と意味をわかりやすく解説
- Dダイマー血液検査：検査結果をわかりやすく解説
- 肺塞栓症：症状・検査・治療
プロテインSの検査結果を自分で確認しようとすると、疑問が増えることも少なくありません。特に、妊娠中やホルモン剤の使用中、または最近血栓ができた場合は、数値に影響が出ている可能性があります。AI DiagMeはあなたの検査レポートを読み取り、総プロテインS・遊離型・活性値など各数値の意味を、医師の診察前にわかりやすい言葉で説明します。このサービスは検査結果を理解するためのものであり、病気の診断や医師への相談に代わるものではありません。
